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Abstract A novel indan derivative, l,l-dimethyl-5-(l-hydroxy-
propyl)-4,6,7-trimethyIindan (Ro 07-3149), was found to be a 
strong inhibitor of the tet(K) gene-encoded tetracycline/H+ 
antiporter of Staphylococcus aureus. One micromole of this 
compound per mg membrane protein was enough for complete 
inhibition of the Tet(K)-mediated tetracycline transport and 
tetracycline-coupled proton transport, without the energy state of 
the membrane being affected. The mode of inhibition was non-
competitive. Although this compound caused membrane de-
energization at a high concentration, the IC50 value for de-
energization (7.3 umol/mg membrane protein) was about 17 
times and 33 times higher than the values for Tet(K)-mediated 
proton/tetracycline antiport and [3H]tetracycline transport, 
respectively, indicating that the inhibitory action of Ro 07-3149 
is not due to the uncoupling effect of the inhibitor. 
© 1997 Federation of European Biochemical Societies. 
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1. Introduction 
Tetracyclines are useful antibiotics and widely used because 
of their broad antimicrobial activity [1]. However, the recent 
increase in microorganisms resistant to tetracyclines has be-
come a problem regarding the use of tetracyclines [1,2]. One 
of the major tetracycline-resistance mechanisms is known to 
be the pumping out of tetracyclines from bacterial cells 
through a specific Tet transporter [1,2]. 
Two classes of efflux proteins are found in Gram-positive 
bacteria, Tet(K) in Staphylococcus aureus [3,4], and Tet(L) in 
Bacillus, Staphylococcus and Streptcoccus species [5,6], where-
as several other classes, such as Tet(A), (B) and (C), are found 
in Gram-negative organisms including Enterobacteriaceae [1]. 
The former and latter types of Tet proteins are greatly differ-
ent from each other not only in molecular size and sequence 
but also in putative membrane topology [7]. However, the two 
types of Tet proteins mediate the efflux of tetracyclines in a 
similar manner, that is, electrically neutral antiport of a met-
al-tetracycline chelation complex with a proton [8-10]. 
Inhibitors of these tetracycline efflux systems are expected 
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to be useful for overcoming the bacterial resistance in combi-
nation with existing tetracyclines, especially in the case of 
methicillin-resistant S. aureus (MRSA), because Tet(K) con-
fers the tetracycline resistance on S. aureus as well as Tet(M) 
based on ribosomal protection [11]. Recently, we screened for 
inhibitors of the tetracycline efflux system in S. aureus by 
measuring the intracellular concentration of [3H]tetracycline 
and found that l ,l-dimethyl-5-(l-hydroxypropyl)-4,6,7-tri-
methylindan (Ro 07-3149, Fig. 1) showed the ability to in-
crease the cellular concentration of tetracycline even in the 
presence of a drug efflux system [12]. However, with such 
indirect measurements it is impossible to determine whether 
inhibition is due to the uncoupling effect of the inhibitor on 
the energized state of the cell membrane. Since the in vitro 
inside-out (ISO) membrane vesicles prepared from S. aureus 
did not work, we transferred the tet(K) gene into E. coli in 
order to perform in vitro experiment. 
In this study, we analyzed the mode of inhibition by Ro 07-
3149 of a tetracycline efflux system using ISO membrane 
vesicles prepared from E. coli cells in which the tet(K) gene 
of S. aureus was constitutively expressed [13]. 
2. Materials and methods 
2.1. Materials 
Ro 07-3149 (Fig. 1) was synthesized at Roche (Nutley, NJ). Tetra-
cycline was obtained from Wako Pure Chemical Industries, Ltd., and 
Sigma. 7-[3H]Tetracycline and [14C]methylamine hydrochloride was 
obtained from DuPont New England Nuclear and Amersham, respec-
tively. Other chemicals were of reagent grade and were from commer-
cial sources. 
2.2. Bacterial strains and plasmids 
E. coli W3104 [14] was used as the host strain for expression of the 
tet(JL) gene and the preparation of ISO membrane vesicles. pTZ1252 
[13] is a plasmid carrying the tet(K) gene for expression in E. coli. 
2.3. Preparation of ISO membrane vesicles 
The preparation of membrane vesicles from E. coli W3104/pTZ1252 
was carried out as described previously [15]. Briefly, cells were grown 
in 1 1 of minimal medium supplemented with 0.2% glucose and 0.1% 
casamino acids until OD530 reached 0.6. ISO vesicles were prepared by 
disruption of cells with a French press in 50 mM MOPS-KOH buffer 
(pH 6.6) containing 0.1 M KC1 and 10 mM EDTA. Then the vesicles 
were washed once with 50 mM MOPS-KOH (pH 7.0) containing 
0.1 M KC1. 
2.4. Measurement of proton translocation as the fluorescence change of 
quinacrine 
Proton translocation across ISO vesicles was measured as the 
change in the fluorescence of quinacrine [16]. A suspension (10 ju.1) 
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of ISO vesicles (5 mg protein/ml) was diluted with 1 ml of 50 mM 
MOPS-KOH (pH 7.0) containing 0.1 M KC1 and 10 mM MgS04 . 
After the addition of 5 ul of 160 uM quinacrine, 0.5-5 ul of 40.6 mM 
Ro 07-3149 in DMSO was added. The membrane vesicles were ener-
gized by adding 2.5 ul of 250 mM B-NADH (final, 625 uM), the 
emission (500 nm)/excitation (440 nm) ratio being monitored. Then, 
10 (j.1 of a 2 mM tetracycline solution (final, 20 uM) was added when 
the ApH formation was completed. Finally, 10 ul of 1 M NH4C1 was 
added to disrupt the ApH. 
2.5. Measurement of [^H] tetracycline and [u CJmethylamine uptake 
by ISO vesicles 
A mixture of 10 ul of the vesicle suspension (3.5 mg/ml) and 0.5 ul 
of 250 mM NADH was pre-incubated at 30°C for 1 min. The uptake 
was started by the addition of [3H]tetracycline (final cone, 10 uM) or 
[14C]methylamine (final cone, 2 mM) in 40 ul of 50 mM MOPS-KOH 
buffer (pH 7.0) containing 0.1 M KC1 and 62.5 (iM CoCl2 (final, 
50 uM), unless otherwise stated. For the inhibition study, 0.5 ul ali-
quots of various concentrations of the inhibitor dissolved in DMSO 
were added simultaneously with tetracycline. After incubation at 30°C 
for the indicated periods, the uptake was stopped by adding 2 ml of 
5 mM MOPS-KOH (pH 7.0) containing 0.15 M LiCl, and then the 
mixture was immediately passed through a Millipore filter (pore size, 
0.45 um), and washed twice with the same buffer. The radioactivity on 
the filter was counted. 
For the kinetic study, the tetracycline concentration was varied 
from 10 to 80 uM in the presence of 800 uM CoCl2. 
3. Results 
3.1. Inhibition of Tet(K)-mediated J3HJ'tetracycline uptake by 
ISO vesicles with Ro 07-3149 
We examined the inhibitory activity of Ro 07-3149 toward 
Tet(K)-mediated tetracycline uptake by ISO membrane 
vesicles prepared from E. coli W3104/pTZ1252. Fig. 2A shows 
the time course of [3H]tetracycline uptake by Tet(K)-contain-
ing ISO membrane vesicles in the presence or absence of Ro 
07-3149. This experiment is a representative one of three in-
dependent experiments. Tetracycline uptake was almost com-
pletely inhibited in the presence of 324 uM Ro 07-3149, while 
in the presence of 162 uM Ro 07-3149, about one-third of the 
uptake activity remained (Fig. 2A). The degree of inhibition 
was dependent on the concentration of Ro 07-3149 relative to 
the total amount of membrane protein, as shown in Fig. 2C. 
The IC50 value was 0.25 umol/mg membrane protein. The 
relative concentration of Ro 07-3149 as to total membrane 
protein reflects the concentration of this compound inside 
the membrane because of the high hydrophobicity of Ro 07-
3149. 
3.2. Effects of Ro 07-3149 on ApH-dependent 
[UCJmethylamine accumulation by ISO vesicles 
Tet(K) proteins mediate the electrically neutral metal-tetra-
cycline/H+ antiport similar to Tet(B) [8]. The Tet(K)-mediated 
tetracycline uptake by ISO vesicles was more than 80% inhib-
ited by the presence of 3.5 ug/ml nigericin, whereas it was 
hardly affected by valinomycin (unpublished observation), in-
dicating that the driving force for the Tet(K)-mediated tetra-
cycline transport is ApH instead of A\|/. Therefore, in order to 
determine whether the inhibition of the Tet(K)-mediated 
tetracycline uptake by ISO vesicles with Ro 07-3149 is due 
to disruption of ApH, we examined the effect of Ro 07-3149 
on ApH-dependent [14C]methylamine accumulation by ISO 
vesicles under the same conditions used for measurement of 
tetracycline uptake. Since a neutral form of weak bases such 
as methylamine can penetrate the lipid bilayer and the 
charged form will accumulate on the acidic side of membrane 
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Fig. 1. Chemical structure of l,l-dimethyl-5-(l-hydroxypropyl)-4,6,7-
trimethyl-indan (Ro 07-3149). 
vesicles, the respiration-driven accumulation of methylamine 
by ISO vesicles is usually used for an indicator of ApH [17]. In 
contrast to tetracycline uptake, ApH-dependent [14C]methyl-
amine uptake was not inhibited by either 165 uM or 325 uM 
Ro 07-3149 (Fig. 2B). Dose dependence of [14C]methylamine 
accumulation on Ro 07-3149 showed that the accumulation 
was not significantly affected by Ro 07-3149 up to 650 uM of 
the inhibitor (Fig. 2C), clearly indicating that the inhibitory 
effect of Ro 07-3149 is not due to the uncoupling effect of the 
inhibitor. 
3.3. Effect of Ro 07-3149 on proton translocation across ISO 
vesicles 
In order to confirm that the inhibitory effect of Ro 07-3149 
on Tet(K) function was not due to the uncoupling effect, we 
next examined the effect of Ro 07-3149 on respiration-depend-
ent proton translocation and Tet(K)-mediated tetracycline-
dependent proton translocation using quinacrine fluorescence. 
When NADH was added, quinacrine fluorescence was 
quenched due to the respiration-dependent proton influx 
into the vesicles (Fig. 3A). When tetracycline was added to 
the energized vesicles, Tet(K)-mediated tetracycline/H+ anti-
port partially collapsed the ApH across the membrane result-
ing in an increase in quinacrine fluorescence (Fig. 3A). When 
41 uM (0.81 umol/mg membrane protein) Ro 07-3149 was 
added prior to the addition of NADH, the Tet(K)-mediated 
tetracycline-dependent fluorescence increase was almost com-
pletely inhibited, without the NADH-induced fluorescence 
quenching being affected (Fig. 3B), clearly confirming that 
the inhibitory action of Ro 07-3149 on the Tet(K) function 
is not due to the uncoupling effect. The inhibition of the 
tetracycline-dependent proton translocation was also depend-
ent on the concentration of Ro 07-3149 (Fig. 4). The IC50 
value was 0.43 umol/mg membrane protein, being similar to 
that of [3H]tetracycline uptake. 
When a high concentration (8.1 umol/mg membrane pro-
tein) of Ro 07-3149 was added before the membrane vesicles 
were energized with NADH, the fluorescence quenching was 
significantly decreased to about 46% of that in the absence of 
Ro 07-3149, reflecting the de-energization caused by Ro 07-
3149 at a high concentration. The dose dependence of 
NADH-dependent ApH formation on Ro 07-3149 in a high 
concentration range is shown in Fig. 4 (inset). The IC50 value 
for NADH-dependent ApH formation was 7.3 umol/mg mem-
brane protein, which was 17 and 33 times higher than those 
for Tet(K)-mediated proton translocation and tetracycline up-
take, respectively. FoFi-ATPase-mediated ATP-dependent 
T. Hirata et allFEBS Letters 412 (1997) 337-340 339 
TIME (sec) 
O 
10-
8-
6-
4 -
2 -
(B) 
• 
£!>^ fr* \^^  I ^ ^ 
,.>:-."-=&=--===---.=::..:o 
,£-''□ □ 
Q 
i ■ i ■ i ■ i 
30 60 90 120 
TIME (sec) 
120 
100 
■g 
w 
a 
CC 
0.2 0.4 0.6 0.8 1 
Ro 07-3149 (umole/mg protein) 
Fig. 2. Effects of Ro 07-3149 on the Tet(K)-mediated [3H]tetracycline uptake and the ApH-dependent accumulation of [14C]methylamine by 
ISO vesicles prepared from E. coli W3104/pTZ1252 cells. A: Time course of [3H]tetracycline uptake by ISO vesicles in the presence of 10 itM 
[3H]tetracycline and 50 uM CoCl2. B: Time course of [
14C]methylamine accumulation by ISO vesicles in the presence of 2 mM [14C]meth-
ylamine. Symbols in (A) and (B): ■. no Ro 07-3149 with 2.5 mM NADH; A, 162 uM Ro 07-3149 with 2.5 mM NADH; • . 325 uM 
Ro 07-3149 with 2.5 mM NADH; □, no Ro 07-3149 without NADH; O, 325 uM Ro 07-3149 without NADH. C: Dose dependence of the 
residual Tet(K)-mediated [3H]tetracycline uptake (O) and the residual ApH-dependent [14C]methylamine accumulation (•) on Ro 07-3149. The 
net residual tetracycline uptake and methylamine accumulation were measured at 30 s after the addition of labeled compounds and indicated 
as a percentage relative to that in the absence of Ro 07-3149. The concentration of Ro 07-3149 was normalized as to the total membrane pro-
tein concentration (0.7 mg/ml). 
ApH formation was also inhibited by Ro 07-3149 (data not 
shown), indicating that Ro 07-3149 acts as a weak uncoupler 
at a high concentration. However, the uncoupling activity of 
Ro 07-3149 was too weak to be detected prior to the inhi-
bition of Tet(K)-mediated tetracycline transport. Therefore, 
Ro 07-3149 was concluded to be a Tet(K)-specific inhibitor. 
3.4. Kinetics of the inhibition of tetracycline uptake by 
Ro 07-3149 
The initial rate of [3H]tetracycline uptake by Tet(K)-con-
taining ISO vesicles was measured in the presence of various 
concentrations of [3H]tetracycline and Ro 07-3149. In the ab-
sence of Ro 07-3149, the apparent Km value for tetracycline 
uptake was 28 uM, which is in good agreement with the 
previously reported value [8]. As shown by Lineweaver-Burk 
plots (Fig. 5), Ro 07-3149 reduced the Fmax value without 
affecting the Km value, indicating that it acts on a non-com-
petitive inhibitor. The K[ value was calculated to be 230 uM 
(0.32 |a.mol/mg protein) by non-linear regression, which was 
similar to the IC50 value for the inhibition of [
3H]tetracycline 
uptake shown in Fig. 2. 
4. Discussion 
Two different kinds of tetracycline efflux pump inhibitors 
have hitherto been reported [18,19]. One of them comprises a 
group of tetracycline derivatives [18] which inhibit the efflux 
pump-mediated tetracycline uptake by ISO vesicles, probably 
in a competitive manner, although a kinetic experiment was 
not performed. The other kind is nocardamine which is not a 
tetracycline derivative. The latter was identified as an antag-
onist of the tetracycline efflux pump in intact cells. However, 
none of them was examined as to whether they indirectly act 
through their uncoupling action. 
Tet(K) mediates metal-tetracycline/H+ antiport similar to 
Tet(B) [8]. The main driving force for Tet(K) is ApH because 
nigericin inhibited the Tet(K)-mediated tetracycline transport 
but valinomycin did not. This behavior of Tet(K) is similar to 
that of Tet(B) [20] and different from the electrogenic nature 
of chromosomally encoded Tet(L) in Bacillus subtilis reported 
by Guffanti and Krulwich [21]. It is clear that Tet(K) and the 
chromosomally encoded Tet(L) have different characteristics 
because unlike Tet(L), Tet(K) does not mediate Na+/H+ anti-
port (unpublished observation). In this manuscript, ApH was 
monitored as a driving force for Tet(K)-mediated tetracycline 
transport. Ro 07-3149 completely inhibited the Tet(K)-medi-
ated [3H]tetracycline uptake by ISO vesicles at the concentra-
tion in which ApH was not affected when monitored with 
[14C]methylamine accumulation. In addition, the IC50 value 
of Ro 07-3149 for ApH disruption monitored with quinacrine 
Fig. 3. Proton translocation across ISO membrane vesicles prepared 
from E. coli W3104/pTZ1252. Proton translocation was measured 
by monitoring the fluorescence quenching of quinacrine. Arrows in-
dicate the times of the addition of the indicated reagents. The final 
concentrations of Ro 07-3149, NADH, tetracycline (TC), and 
NH4CI were 41, 625, 20, and 10 uM, respectively. 
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Fig. 4. The effect of Ro 07-3149 on the /ei(K)-mediated proton translocation activity (■), and NADH-dependent ApH formation activity (o) 
of Tet(K)-containing ISO vesicles, as measured as the fluorescence quenching of quinacrine. The concentration of Ro 07-3149 was normalized 
as to the total membrane protein concentration (0.05 mg/ml). Inset: results in the presence of a high concentration of Ro 07-3149. 
fluorescence change was at least 17 times higher than that for 
inhibition of tetracycline-dependent pro ton translocation 
mediated by Tet(K). Therefore, it can be concluded that the 
inhibitory action of R o 07-3149 on Tet(K) function is not due 
to the uncoupling effect. 
Minimum inhibitory concentration (MIC) of tetracycline 
and R o 07-3149 against S. aureus cells carrying tet(K) gene 
was 64 and 32 (j.g/ml, respectively. In the presence of 8 |J.g/ml 
of R o 07-3149, the M I C value of tetracycline was reduced to 
32 |j,g/ml. In contrast, Ro 07-3149 showed neither antibacte-
rial activity nor synergistic effect for tetracycline action 
against E. coli cells carrying pTZ1252, probably due to the 
low permeability of R o 07-3149 across the outer membrane. 
Anyway, R o 07-3149 is a first compound established as a non-
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Fig. 5. Lineweaver-Burk plots of the initial rate (15 s) of [3H]tetra-
cycline uptake by Tet(K)-containing ISO vesicles against tetracycline 
concentration. ■, no Ro 07-3149; O, 81 uM (0-12 umol/mg pro-
tein); ▲ , 162 uM (0.23 umol/mg protein); □, 244 uM (0.35 umol/ 
mg protein) of Ro 07-3149. 
competitive inhibitor of Tet(K) clearly not due to the uncou-
pling action. 
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